LAURUSLABS.NS

Laurus Labs Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,412.90

+3.28%Jun 19, 2026

AI Brief

Market cap

$762.76B

52w range

—

P / E

—

EPS · FY 2026

$16.45

Volume

—

Revenue · FY 2026

$68.13B

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Laurus Labs Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1412.90

Change

+112.05%

Period high

$1446.80

Period low

$666.30

Period start

$666.302025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$367.16

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

LAURUSLABS.NS

1,413+112.05%

H 1,457L 647.00MA50 1,266MA200 1,053Avg vol 2.0M

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Sector & industry today

Live

Sectors

Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Energy
-0.45%
Industrials
-0.48%
Basic Materials
-0.66%
Financial Services
-0.67%
Technology
-0.95%
Healthcare
-1.51%
Consumer Defensive
-1.52%
Real Estate
-2.19%

Top industries (issuer's industry highlighted)

No industry data returned.

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for LAURUSLABS.NS.

Peers

No peer list available for LAURUSLABS.NS.

Total assets

$105.11B

Total debt

$25.18B

Cash & equiv

$1.14B

Operating CF

$14.59B

Free cash flow

$3.89B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$68.13B	$12.98B	$8.89B	$16.45	+13.05%